Xylem
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	12/31/2021	12/31/2022	12/31/2023	12/31/2025	12/31/2026	12/31/2027
Revenue % change YoY	$5.19B N/A	$5.52B 6.29%	$7.36B 33.35%	Avg: $9.03B Low: $8.91B High: $9.15B avg. 22.64%	Avg: $9.53B Low: $9.40B High: $9.65B avg. 5.52%	Avg: $10.05B Low: $9.91B High: $10.18B avg. 5.49%
Net Income % change YoY	$427M N/A	$355M -16.86%	$609M 71.54%	Avg: $1.01B Low: $730.90M High: $1.04B avg. 66.49%	Avg: $1.15B Low: $970.90M High: $1.18B avg. 13.43%	Avg: $1.33B Low: $1.30B High: $1.35B avg. 15.91%
EBITDA % change YoY	$837M N/A	$754M -9.91%	$1.15B 52.51%	Avg: $1.42B Low: $1.40B High: $1.44B avg. 24.18%	Avg: $1.50B Low: $1.48B High: $1.52B avg. 5.52%	Avg: $1.58B Low: $1.56B High: $1.61B avg. 5.49%
EPS % change YoY	$2.37 N/A	$1.97 -16.87%	$2.81 42.63%	Avg: $4.06 Low: $3.35 High: $4.81 avg. 44.32%	Avg: $4.85 Low: $4.45 High: $5.45 avg. 19.48%	Avg: $6.11 Low: $6 High: $6.21 avg. 26.09%
Operating Expenses % change YoY	$1.38B N/A	$1.43B 3.61%	$2.06B 44.10%	Avg: $2.06B Low: $2.03B High: $2.09B avg. -0.04%	Avg: $2.17B Low: $2.14B High: $2.20B avg. 5.52%	Avg: $2.29B Low: $2.26B High: $2.32B avg. 5.49%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of 31.94% in 2025-2027.

We have gathered data from 12 analysts. Their low estimate is 730.90M, average is 1.01B and high is 1.04B.

Wall Street analysts forecast annual average revenue growth of 11.22% in 2025-2027.

We have gathered data from 14 analysts. Their low revenue estimate is $8.91B, average is $9.03B and high is $9.15B.

Wall Street analysts forecast annual average earnings growth of 29.96% in 2025-2027.

We have gathered data from 12 analysts. Their low earnings per share estimate is $3.35, average is $4.06 and high is $4.80.

In the last twelve months analysts have been covering Xylem stock. The most successful analyst is Bryan Blair.